<DOC>
	<DOC>NCT01463631</DOC>
	<brief_summary>This study evaluates the safety and tolerability of different doses of an experimental treatment in participants with advanced cancer.</brief_summary>
	<brief_title>A Study of LY3007113 in Participants With Advanced Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Have histological or cytological evidence of a diagnosis of cancer that is advanced and/or metastatic for which available standard therapies have failed to provide clinical benefit for their disease For Dose Escalation (Part A): cancer, either a solid tumor or a lymphoma For Dose Confirmation (Part B): cancer, either a solid tumor or a lymphoma Have the presence of measureable or nonmeasureable disease (Part A) or measureable disease (Part B) as defined by the Response Evaluation Criteria in Solid Tumors or the Revised Response Criteria for Malignant Lymphoma Have adequate hematologic, hepatic and renal function Have a performance status less than or equal to 2 on the Eastern Cooperative Oncology Group scale Have discontinued all previous therapies for cancer (including chemotherapy, radiotherapy, and immunotherapy) for at least 21 days for myelosuppressive agents or 14 days for nonmyelosuppressive agents Have an estimated life expectancy of greater than or equal to 12 weeks Are able to swallow capsules Have an echocardiogram with clinically significant abnormalities For Dose Escalation (Part A): Have central nervous system malignancy or metastasis For Dose Confirmation (Part B): Have symptomatic central nervous system malignancy or metastasis Have an acute leukemia Have a history of any other cancer (except nonmelanoma skin cancer or carcinoma insitu of the cervix), unless in complete remission and stopped all therapy for that disease for a minimum of 3 years Have received an autologous or allogeneic stemcell transplant within 75 days of the initial dose of study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>